Trend Exploration, Inc. (TRDX) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerTrend Exploration, Inc. (TRDX) trades at $0.023. Trend Exploration, Inc. operates as a supplier of products for the medical, dental, and veterinary communities. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for TRDX: TRDX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
Trend Exploration, Inc. (TRDX) Financial Services Profile
Trend Exploration, Inc., established in 1987, supplies a comprehensive range of medical, dental, and veterinary products. Operating in the financial services sector as a shell company, it offers diverse products from acrylics to X-ray supplies, serving healthcare communities from its base in Jericho, New York.
What Is the Investment Thesis for TRDX?
Trend Exploration, Inc. presents a speculative investment opportunity due to its status as an OTC-listed shell company operating in the medical supply sector. With a negative P/E ratio of -27.09 and a Beta of -0.24, the company's financial performance and market sensitivity require careful consideration. Growth catalysts may include expansion of product lines or strategic partnerships within the medical, dental, and veterinary markets. However, the company's OTC listing and shell company classification introduce significant risks, including limited liquidity, regulatory scrutiny, and potential delisting. Investors should conduct thorough due diligence, focusing on the company's financial disclosures, operational activities, and compliance with regulatory requirements. The absence of a dividend further underscores the speculative nature of this investment, with potential returns dependent on successful execution of growth strategies and improved financial performance.
Based on FMP financials and quantitative analysis
TRDX Key Highlights
Negative P/E ratio of -27.09, indicating the company is currently not profitable.
- Beta of -0.24, suggesting the stock price is less volatile than the overall market.
- Operates as a supplier of products for medical, dental, and veterinary communities.
- Listed on the OTC market, which typically involves higher risks and lower liquidity compared to major exchanges.
- Classified as a shell company, indicating a need for thorough due diligence and risk assessment.
Who Are TRDX's Competitors?
TRDX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| DTSQ DT Cloud Star Acquisition Corporation | $11.52 | -0.52% | $42.1M | 49 5-pillar |
| XXI Twenty One Capital Inc | $6.39 | -2.14% | $66.0M | 39 5-pillar |
| CHPG ChampionsGate Acquisition Corporation | $10.50 | +0.38% | $105M | 49 5-pillar |
| ACOG Alpha Cognition Inc. | $9.04 | +0.67% | $142M | — |
| RILY BRC Group Holdings, Inc. | $4.99 | +0.40% | $201M | 63 5-pillar |
| BIII Black Spade Acquisition III Co | $10.05 | 0.00% | $233M | 63 5-pillar |
| BLRK Bluerock Acquisition Corp. Class A Ordinary Shares | $10.13 | -0.00% | $233M | 65 5-pillar |
| IRHO Iron Horse Acquisitions II Corp. Common Stock | $10.09 | +0.20% | $236M | 46 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TRDX's Key Strengths?
Wide range of product offerings.
- Established presence in the industry.
- Serves multiple healthcare sectors (medical, dental, veterinary).
- Potential for strong customer relationships.
What Are TRDX's Weaknesses?
OTC listing indicates higher risk and lower liquidity.
- Classification as a shell company raises regulatory concerns.
- Negative P/E ratio suggests current lack of profitability.
- Limited information available due to OTC status.
What Could Drive TRDX Stock Higher?
Potential expansion of product lines to include specialized medical, dental, and veterinary supplies.
- Strategic partnerships with established manufacturers to enhance product offerings and market reach.
- Development and launch of an online sales platform to reach a wider customer base.
- Geographic expansion into new markets with growing healthcare industries.
What Are the Key Risks for TRDX?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the medical supply industry.
- Regulatory changes and compliance requirements affecting the company's operations.
- Economic downturn leading to reduced healthcare spending.
- Limited financial disclosure due to OTC listing and shell company status.
- Risk of delisting from the OTC market.
What Are the Growth Opportunities for TRDX?
- Expansion of Product Lines: Trend Exploration could expand its product lines to include more specialized or high-margin items, such as advanced dental materials or surgical instruments. The market for these products is growing as healthcare providers seek innovative solutions to improve patient outcomes. By focusing on niche markets within the medical, dental, and veterinary sectors, the company could differentiate itself from larger competitors and increase its revenue potential. The timeline for this growth opportunity is dependent on market research and product development, but could yield results within 1-3 years.
- Strategic Partnerships: Forming strategic partnerships with established medical, dental, or veterinary product manufacturers could provide Trend Exploration with access to new products and markets. These partnerships could also enhance the company's credibility and reputation within the industry. By leveraging the resources and expertise of its partners, Trend Exploration could accelerate its growth and expand its customer base. The timeline for establishing strategic partnerships is dependent on negotiations and due diligence, but could be achieved within 6-12 months.
- Online Sales Platform: Developing an online sales platform could enable Trend Exploration to reach a wider customer base and streamline its sales process. The e-commerce market for medical, dental, and veterinary supplies is growing rapidly, as healthcare providers increasingly prefer the convenience and efficiency of online ordering. By investing in a user-friendly online platform, Trend Exploration could enhance its customer service and increase its sales volume. The timeline for developing an online sales platform is dependent on software development and marketing efforts, but could be launched within 12-18 months.
- Geographic Expansion: Expanding its geographic reach could provide Trend Exploration with access to new markets and customers. The company could target regions with growing healthcare industries or underserved medical, dental, and veterinary communities. By establishing a presence in new geographic areas, Trend Exploration could diversify its revenue streams and reduce its reliance on its existing customer base. The timeline for geographic expansion is dependent on market research and logistical considerations, but could be implemented within 2-3 years.
- Focus on Private Label Products: Developing and marketing private label products could allow Trend Exploration to increase its profit margins and build brand loyalty. By offering its own branded products, the company could differentiate itself from competitors and create a unique value proposition for its customers. The market for private label medical, dental, and veterinary supplies is growing, as healthcare providers seek cost-effective alternatives to established brands. The timeline for developing private label products is dependent on product development and marketing efforts, but could yield results within 1-2 years.
What Are TRDX's Competitive Advantages?
- Wide product range catering to diverse needs.
- Established relationships with suppliers.
- Long-standing presence in the industry (since 1987).
- Potential for customer loyalty through consistent product availability.
What Does TRDX Do?
Founded in 1987 and based in Jericho, New York, Trend Exploration, Inc. focuses on supplying products to the medical, dental, and veterinary communities. The company offers an extensive range of products, including acrylics, alloys, anesthetics, articulating products, burs and diamonds, cements, core materials, cosmetics, crowns, dentures, disposables, endodontics, evacuation products, filling products, finishing materials, infection control products, instruments, lab supplies, medicaments, orthodontics, pins and posts, preventive dentistry products, prophy products, retraction products, rubber dams, handpieces, surgical products, and X-ray products. Trend Exploration's business model centers on sourcing and distributing these products to healthcare providers. The company aims to be a one-stop shop for medical, dental, and veterinary professionals, providing a broad selection of supplies needed for their practices. While specific market share data is unavailable, Trend Exploration operates within a fragmented market with numerous competitors, requiring a focus on customer service and product availability to maintain its position. The company's long-standing presence in the industry suggests established relationships with suppliers and customers. However, its classification as a shell company introduces additional layers of scrutiny and risk. The company's success depends on its ability to efficiently manage its supply chain, maintain competitive pricing, and adapt to evolving healthcare industry standards and regulations. Given its OTC listing and shell company status, transparency and regulatory compliance are critical for investor confidence and long-term viability.
What Products and Services Does TRDX Offer?
- Supplies products for medical communities.
- Offers products for dental communities.
- Provides products for veterinary communities.
- Distributes acrylics, alloys, and anesthetics.
- Sells articulating products, burs, and diamonds.
- Markets cements, core materials, and cosmetics.
- Offers crowns, dentures, and disposables.
- Provides endodontics, evacuation products, and filling products.
How Does TRDX Make Money?
- Procures medical, dental, and veterinary supplies from various manufacturers.
- Distributes these supplies to healthcare providers.
- Generates revenue through the sale of these products.
- Focuses on providing a wide range of products to meet diverse customer needs.
What Industry Does TRDX Operate In?
Trend Exploration, Inc. operates within the broader medical, dental, and veterinary supply industry, which is characterized by a large number of players and diverse product offerings. The industry is influenced by factors such as technological advancements, regulatory changes, and healthcare spending trends. Competition is intense, with companies vying for market share through product innovation, pricing strategies, and customer service. As a shell company listed on the OTC market, Trend Exploration faces additional challenges related to regulatory compliance and investor confidence. The company's success depends on its ability to differentiate itself through product specialization, efficient operations, and strong customer relationships.
Who Are TRDX's Key Customers?
- Medical professionals and clinics.
- Dental practices and dentists.
- Veterinary clinics and veterinarians.
- Hospitals and healthcare institutions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Company Profile
Trend Exploration, Inc. operates in the Financial Services sector. It is headquartered in Jericho, US. The company is led by CEO Cheng-Che Lee. TRDX has traded publicly since 2021.
Financial Health
Trend Exploration, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
TRDX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Wide range of product offerings.
- Established presence in the industry.
- Serves multiple healthcare sectors (medical, dental, veterinary).
- Potential for strong customer relationships.
Bear Case
- OTC listing indicates higher risk and lower liquidity.
- Classification as a shell company raises regulatory concerns.
- Negative P/E ratio suggests current lack of profitability.
- Limited information available due to OTC status.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TRDX Latest News
No recent news available for TRDX.
TRDX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TRDX.
Price Targets
Wall Street price target analysis for TRDX.
TRDX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for TRDX; grades run from A+ (80-100) to F (below 30).
TRDX OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Trend Exploration, Inc. may not meet the minimum financial or disclosure requirements of the higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available to the public and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for fraud, lack of liquidity, and limited transparency. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- OTC Tier: OTC Other
- Limited financial disclosure due to OTC Other tier status.
- Potential for fraud or manipulation due to less regulatory oversight.
- Low trading volume and liquidity, making it difficult to buy or sell shares.
- Higher price volatility compared to stocks listed on major exchanges.
- Risk of delisting or suspension from the OTC market.
- Verify the company's registration and compliance with regulatory requirements.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and track record.
- Investigate any potential red flags, such as legal issues or regulatory actions.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Company has been in business since 1987.
- Provides a specific range of products for medical, dental, and veterinary communities.
- Headquarters located in Jericho, New York.
- Presence of a business description outlining the company's activities.
TRDX Financials Stock FAQ
Is TRDX a good stock to buy?
Stock Expert AI does not rate TRDX buy, sell or hold. Trend Exploration, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the TRDX stock price today?
The last price recorded on this page for Trend Exploration, Inc. (TRDX) is $0.023, as of the Oct 6, 2026 trading session. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for TRDX?
The main risks for Trend Exploration, Inc. include its OTC listing, which indicates higher risk and lower liquidity compared to stocks listed on major exchanges.
What are the key factors to evaluate for TRDX?
Evaluate TRDX on fundamentals, analyst consensus, and risk factors. Trend Exploration, Inc. presents a speculative investment opportunity due to its status as an OTC-listed shell company operating in the medical supply sector. Not financial advice.
How frequently does TRDX data refresh on this page?
TRDX's price is the last quote we recorded, from the Oct 6, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven TRDX's recent stock price performance?
Trend Exploration, Inc. (TRDX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Wide range of product offerings. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TRDX overvalued or undervalued right now?
Trend Exploration, Inc. (TRDX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TRDX before investing?
Before investing in Trend Exploration, Inc. (TRDX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available due to OTC listing and shell company status.
- Financial data may not be fully reliable due to limited disclosure requirements.